The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.

In vitro skin irritation testing has emerged as a critical component in the safety evaluation of chemicals and medical devices, aiming to replace traditional animal-based assays. Central to this ...

A federal district court has struck a blow for medical innovation and patient empowerment by overruling the Food and Drug Administration's (FDA) misbegotten effort to regulate laboratory-developed ...

In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...

Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...

NEW YORK CITY, NY, UNITED STATES, February 10, 2025 /EINPresswire.com/ -- Creative Bioarray, a pioneer in providing innovative solutions for biological research and ...

PHOENIX, Ariz., March 24, 2025 /PRNewswire/ - SGS, the world's leading testing, inspection, and certification company, has gained ISO 17025 accreditation for its Phoenix, Arizona laboratory that ...